Pentapeptide-3 | CAS:135679-88-8

We serve Pentapeptide-3 CAS:135679-88-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Pentapeptide-3

Chemical Name:Pentapeptide-3
CAS.NO:135679-88-8
Synonyms:Pentapeptide-3
Glycyl-L-prolyl-L-arginyl-L-prolyl-L-alaninamide
Vialox
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Molecular Formula C21H37N9O5
Molecular Weight 495.576
Index of Refraction 1.691
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Applicationd as Peptide for cosmetics.



Contact us for information like Pentapeptide-3 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Vialox physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Glycyl-L-prolyl-L-arginyl-L-prolyl-L-alaninamide Use and application,Pentapeptide-3 technical grade,usp/ep/jp grade.


Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.6-Hydroxy-5-nitropyridine-3-carboxylic acid manufacturer On Friday, US Health and Human Services Secretary Alex Azar declared the 2019 novel coronavirus a public health emergency and ordered any US citizens returning from the center of the outbreak in China to be quarantined for two weeks as a precaution.Ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate supplier Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Ethyl linolenate vendor Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.